IBN (IBN) Stock Price & Analysis
IBN (IBN) rose 2.30% to USD 26.29 as of June 9, 2026 at 23:46 UTC, according to Nexqual real-time market data.
IBN last closed at USD 25.7; the session ranged USD 26.1–26.49 on volume of 11,151,236 shares. Market capitalization is $94.26B, with a 52-week range of USD 25.08–34.57 (NYQ). Source: Nexqual, June 9, 2026 at 23:46 UTC.
Key Statistics (as of June 9, 2026 at 23:46 UTC)
| Price | USD 26.29 |
|---|---|
| Change | ▲ 2.30% (up) |
| Previous Close | USD 25.7 |
| Open | USD 26.66 |
| Day Range | USD 26.1 – 26.49 |
| 52-Week Range | USD 25.08 – 34.57 |
| Volume | 11,151,236 shares |
| Market Cap | $94.26B |
| Exchange | NYQ |
Technical Analysis (IBN)
Nexqual's technical model rates IBN "SELL" based on 2 bullish and 4 bearish signals across 124 daily candles, as of June 9, 2026 at 23:46 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 47.74 (neutral) |
| vs SMA50 | Below (USD 26.61) |
| MACD | -0.2 (negative) |
Analyst Ratings (IBN)
Wall Street analysts rate IBN "None" based on 4 analysts, with a mean price target of USD 35.38 (range USD 34–37), per Nexqual as of June 9, 2026 at 23:46 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 4 |
| Mean Target | USD 35.38 |
| High Target | USD 37 |
| Low Target | USD 34 |
| Buy / Hold / Sell | 4 / 0 / 0 |
Earnings (IBN)
| Next Earnings Date | 2026-07-18 |
|---|---|
| EPS Estimate | USD 0.41 |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0.41 vs est 0.39 ▲ beat |
| 2025-12-31 | USD 0.34 vs est 0.38 ▼ miss |
| 2025-09-30 | USD 0.39 vs est 0.36 ▲ beat |
| 2025-06-30 | USD 0.41 vs est 0.39 ▲ beat |
Source: Nexqual, June 9, 2026 at 23:46 UTC.
Financials & Fundamentals (IBN)
| Total Revenue | $2.17T |
|---|---|
| Revenue Growth (YoY) | +66.90% |
| Gross Margin | +0.00% |
| Operating Margin | +33.29% |
| Profit Margin | +24.93% |
| ROE | +16.36% |
| Total Cash | $2.65T |
| Total Debt | $2.20T |
Source: Nexqual, June 9, 2026 at 23:46 UTC.
Financial Health Score (IBN)
Nexqual rates IBN's overall financial health "Weak" across five dimensions, as of June 9, 2026 at 23:46 UTC.
| Growth | Critical — Revenue -42% YoY (annual), sharp decline |
|---|---|
| Profitability | Critical — Gross margin 0% |
| Balance Sheet | Mixed — $2.65T cash vs $2.20T debt, net cash position |
| Cash Flow | Weak — Operating cash flow -$1.21T |
| Efficiency | Solid — ROE 16%, ROA 2.1% |
Ownership (IBN)
| Insider Ownership | +0.22% |
|---|---|
| Institutional Ownership | +17.67% |
| Shares Outstanding | 3.59B |
| Float | 3.57B |
| Short % of Float | +1.55% |
Source: Nexqual, June 9, 2026 at 23:46 UTC.
Leadership (IBN)
IBN is led by Sandeep Bakhshi B.E. (age 65), MD, CEO & Executive Director, per Nexqual as of June 9, 2026 at 23:46 UTC.
| MD, CEO & Executive Director | Sandeep Bakhshi B.E. (age 65) |
|---|---|
| Executive Director | Rakesh Jha BE, PGDM (age 53) |
| Executive Director | Sandeep Batra A.C.S., B.Com., CA, CS, F.C.A. (age 59) |
| Executive Director | Ajay Kumar Gupta B.Com, CA (age 58) |
| Group CFO & Head of Investor Relations | Anindya Banerjee (age 49) |
Major Backers & Investors (IBN)
Notable institutional backers of IBN include GQG Partners LLC, Morgan Stanley, WCM Investment Management, LLC, according to Nexqual as of June 9, 2026 at 23:46 UTC.
Active Investors
| Investor | Stake |
|---|---|
| GQG Partners LLC | 2.16% |
| Morgan Stanley | 1.5% |
| WCM Investment Management, LLC | 1.46% |
| Goldman Sachs | 1.21% |
| Temasek Holdings (Private) Ltd | 0.81% |
| Invesco | 0.61% |
| Robeco Institutional Asset Management B.V. | 0.55% |
| FIL LTD | 0.39% |
Source: Nexqual, June 9, 2026 at 23:46 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| HDB | HDFC Bank Limited | USD 23.29 | ▼ 0.51% |
| WIT | Wipro Limited | USD 2.16 | ▲ 2.86% |
| RDY | Dr. Reddy's Laboratories Ltd | USD 13.37 | ▲ 0.98% |
| INFY | Infosys Limited | USD 12.24 | ▼ 1.29% |
| SAY | Saratoga Investment Corp 8.125% | USD 25.26 | ▼ 0.37% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 9, 2026 at 23:46 UTC. This page is informational and not investment advice.